Dr. Martens Statistics

Total Valuation

Dr. Martens has a market cap or net worth of GBP 698.65 million. The enterprise value is 1.05 billion.

Market Cap	698.65M
Enterprise Value	1.05B

Important Dates

The next estimated earnings date is Thursday, June 5, 2025.

Earnings Date	Jun 5, 2025
Ex-Dividend Date	Mar 6, 2025

Share Statistics

Dr. Martens has 964.32 million shares outstanding. The number of shares has decreased by -4.20% in one year.

Current Share Class	n/a
Shares Outstanding	964.32M
Shares Change (YoY)	-4.20%
Shares Change (QoQ)	-2.45%
Owned by Insiders (%)	2.05%
Owned by Institutions (%)	47.26%
Float	516.84M

Valuation Ratios

The trailing PE ratio is 23.78 and the forward PE ratio is 17.21.

PE Ratio	23.78
Forward PE	17.21
PS Ratio	0.86
PB Ratio	2.08
P/TBV Ratio	11.51
P/FCF Ratio	3.23
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.72, with an EV/FCF ratio of 4.87.

EV / Earnings	35.83
EV / Sales	1.31
EV / EBITDA	7.72
EV / EBIT	14.84
EV / FCF	4.87

Financial Position

The company has a current ratio of 2.26, with a Debt / Equity ratio of 1.34.

Current Ratio	2.26
Quick Ratio	0.98
Debt / Equity	1.34
Debt / EBITDA	3.29
Debt / FCF	2.08
Interest Coverage	2.28

Financial Efficiency

Return on equity (ROE) is 8.42% and return on invested capital (ROIC) is 5.32%.

Return on Equity (ROE)	8.42%
Return on Assets (ROA)	4.53%
Return on Capital (ROIC)	5.32%
Revenue Per Employee	306,426
Profits Per Employee	11,179
Employee Count	2,630
Asset Turnover	0.82
Inventory Turnover	0.99

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -7.09% in the last 52 weeks. The beta is 0.04, so Dr. Martens's price volatility has been lower than the market average.

Beta (5Y)	0.04
52-Week Price Change	-7.09%
50-Day Moving Average	68.21
200-Day Moving Average	69.85
Relative Strength Index (RSI)	53.62
Average Volume (20 Days)	825,502

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Dr. Martens had revenue of GBP 805.90 million and earned 29.40 million in profits. Earnings per share was 0.03.

Revenue	805.90M
Gross Profit	528.00M
Operating Income	71.00M
Pretax Income	38.50M
Net Income	29.40M
EBITDA	84.40M
EBIT	71.00M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 94.90 million in cash and 449.70 million in debt, giving a net cash position of -354.80 million or -0.37 per share.

Cash & Cash Equivalents	94.90M
Total Debt	449.70M
Net Cash	-354.80M
Net Cash Per Share	-0.37
Equity (Book Value)	334.50M
Book Value Per Share	0.35
Working Capital	243.20M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 226.70 million and capital expenditures -10.60 million, giving a free cash flow of 216.10 million.

Operating Cash Flow	226.70M
Capital Expenditures	-10.60M
Free Cash Flow	216.10M
FCF Per Share	0.22

Full Cash Flow Statement

Margins

Gross margin is 65.52%, with operating and profit margins of 8.81% and 3.65%.

Gross Margin	65.52%
Operating Margin	8.81%
Pretax Margin	4.78%
Profit Margin	3.65%
EBITDA Margin	10.47%
EBIT Margin	8.81%
FCF Margin	26.81%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 3.52%.

Dividend Per Share	0.03
Dividend Yield	3.52%
Dividend Growth (YoY)	-56.34%
Years of Dividend Growth	n/a
Payout Ratio	51.02%
Buyback Yield	4.20%
Shareholder Yield	7.72%
Earnings Yield	4.21%
FCF Yield	30.93%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Dr. Martens has an Altman Z-Score of 4.86.

Altman Z-Score	4.86
Piotroski F-Score	n/a